Show items per page
Elements: 46
Page 2 on 3
 TitleAuthors / EditorsDate
add to browser selection
High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy Laurent, C.; Bourgeois, A.; Mpoudi-Ngole, Eitel; Kouanfack, C.; ... Delaporte, E. 2010
add to browser selection
Highly loaded nanoparticulate carrier using an hydrophobic antisense oligonucleotide complex Berton, Myriam; Allémann, Eric; Stein, Cy A.; Gurny, Robert 1999
add to browser selection
HIV-1 co/super-infection in intravenous drug users Yerly Ferrillo, Sabine; Jost, Stéphanie; Monnat, Martine; Telenti, Amalio; ... Perrin, Luc 2004
add to browser selection
HIV-1 innate immune detection and evasion Reinhard, Christian 2013
add to browser selection
HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4(+) T cell loss Schupbach, Jorg; Gunthard, Huldrych; Joos, Beda; Fischer, Marek; ... Hirschel, Bernard 2005
add to browser selection
HLA antigens are risk factors for development of AIDS Jeannet, Michel; Sztajzel, Roman; Carpentier, N.; Hirschel, Bernard; Tiercy, Jean-Marie 1989
add to browser selection
Impact of highly active antiretroviral therapy on the molecular epidemiology of newly diagnosed HIV infections Ambrosioni Czyrko, Juan; Junier, Thomas; Delhumeau, Cécile; Calmy, Alexandra; ... Yerly Ferrillo, Sabine 2012
add to browser selection
Initial treatment for HIV infection--an embarrassment of riches Hirschel, Bernard; Calmy, Alexandra 2008
add to browser selection
Innate immune signaling and the contribution of different regions of capsid to HIV-1 restriction by TRIM5 Lascano Maillard, Maria Josefina 2014
add to browser selection
Is it smart to continue to study treatment interruptions? Hirschel, Bernard; Flanigan, Timothy 2009
add to browser selection
Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study Rutschmann, Olivier Thierry; Vernazza, P. L.; Bucher, H. C.; Opravil, M.; ... Hirschel, Bernard 2000
add to browser selection
Long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced HIV-infected children Rudin, Christoph; Burri, Marcus; Shen, Yang; Rode, Richard; Nadal, David 2008
add to browser selection
Mechanisms involved in the low-level regeneration of CD4+ cells in HIV-1-infected patients receiving highly active antiretroviral therapy who have prolonged undetectable plasma viral loads Benveniste, Olivier; Flahault, Antoine; Rollot, Florence; Elbim, Carole; ... Leport, Catherine 2005
add to browser selection
Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival Staehelin, Cornelia; Rickenbach, Martin; Low, Nicola; Egger, Martin; ... Furrer, Hansjakob 2003
add to browser selection
Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population Jaggy, Christian; von Overbeck, Jan; Ledergerber, Bruno; Schwarz, Claude; ... Hirschel, Bernard 2003
add to browser selection
p62/sequestosome-1 associates with and sustains the expression of retroviral restriction factor TRIM5alpha O'Connor, Christopher; Pertel, Thomas; Gray, Seth; Robia, Seth L.; ... Campbell, Edward M. 2010
add to browser selection
Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study Thierfelder, C; Weber, R; Elzi, L; Furrer, H; ... Ledergerber, B 2012
add to browser selection
Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era Boffi El Amari, Emmanuelle; Toutous-Trellu, Laurence; Gayet-Ageron, Angèle; Baumann, Michele; ... Hirschel, Bernard 2008
add to browser selection
Response to treatment and disease progression linked to CD4+ T cell surface CC chemokine receptor 5 density in human immunodeficiency virus type 1 vertical infection Gervaix, Alain; Nicolas, Joëlle; Portales, Pierre; Posfay Barbe, Klara; ... Corbeau, Pierre 2002
add to browser selection
Severity and prognosis of acute human immunodeficiency virus type 1 illness: a dose-response relationship Vanhems, P.; Lambert, J.; Cooper, David; Perrin, Luc; ... Allard, Robert 1998
| 1 | 2 | 3 |